Celcuity Inc. (CELC) financial statements (2021 and earlier)

Company profile

Business Address 16305 36TH AVENUE N
MINNEAPOLIS, MN 55446
State of Incorp. DE
Fiscal Year End December 31
SIC 8071 - Medical Laboratories (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments11,63818,73524,89824,197
Cash and cash equivalents11,63818,73515,9452,640
Short-term investments  8,95321,557
Restricted cash and investments   50
Receivables190190  
Prepaid expense317275270210
Deferred costs 2929 
Deposits current assets22222228
Total current assets:12,16719,25025,21824,484
Noncurrent Assets
Finance lease, right-of-use asset(49) 
Operating lease, right-of-use asset231197
Property, plant and equipment559833814280
Long-term investments and receivables   7,205
Long-term investments   7,205
Other undisclosed noncurrent assets49   
Total noncurrent assets:7901,0308147,485
TOTAL ASSETS:12,95720,28126,03231,970
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities992727657578
Accounts payable21714312072
Accrued liabilities775584537506
Debt1931846 
Total current liabilities:1,185911662578
Noncurrent Liabilities
Long-term debt and lease obligation697220 
Finance lease, liability814
Capital lease obligations20 
Operating lease, liability6158
Total noncurrent liabilities:697220 
Total liabilities:1,254983682578
Stockholders' equity
Stockholders' equity attributable to parent11,70219,29825,35031,391
Common stock10101010
Additional paid in capital38,01436,13534,82733,389
Accumulated deficit(26,322)(16,847)(9,488)(2,007)
Total stockholders' equity:11,70219,29825,35031,391
TOTAL LIABILITIES AND EQUITY:12,95720,28126,03231,970

Income statement (P&L) ($ in thousands)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
Operating expenses(9,556)(7,805)(7,933)(5,953)
Operating loss:(9,556)(7,805)(7,933)(5,953)
Nonoperating income (expense)82446452(299)
Investment income, nonoperating82446449153
Interest and debt expense(0)(0)(0)(452)
Loss from continuing operations before equity method investments, income taxes:(9,474)(7,360)(7,481)(6,703)
Other undisclosed income from continuing operations before income taxes000452
Net loss available to common stockholders, diluted:(9,474)(7,359)(7,481)(6,252)

Comprehensive Income ($ in thousands)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(9,474)(7,359)(7,481)(6,252)
Comprehensive loss, net of tax, attributable to parent:(9,474)(7,359)(7,481)(6,252)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: